ICD-10-CM Diagnosis Code J84.03 - Idiopathic pulmonary hemosiderosis (original) (raw)
ICD List 2025-2026 Edition
- Home
- ICD-10-CM Codes
- J00–J99
- J80-J84
- J84
- 2026 ICD-10-CM Code J84.03
Idiopathic pulmonary hemosiderosis
ICD-10-CM Code:
J84.03
ICD-10 Code for:
Idiopathic pulmonary hemosiderosis
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:
J84.03 is a billable diagnosis code used to specify a medical diagnosis of idiopathic pulmonary hemosiderosis. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2025 through September 30, 2026.
- Code Information
- Approximate Synonyms
- Clinical Classification
- Clinical Information
- Tabular List of Diseases and Injuries
- Index to Diseases and Injuries References
- Code Edits
- Diagnostic Related Groups Mapping
- Convert to ICD-9 Code
- Patient Education
- Other Codes Used Similar Conditions
- Code History
- Diseases of the respiratory system
J00–J99
The following list of clinical terms are approximate synonyms, alternative descriptions, or common phrases that might be used by patients, healthcare providers, or medical coders to describe the same condition. These synonyms and related diagnosis terms are often used when searching for an ICD-10 code, especially when the exact medical terminology is unclear. Whether you're looking for lay terms, similar diagnosis names, or common language alternatives, this list can help guide you to the correct ICD-10 classification.
- Hemosiderosis
- Idiopathic pulmonary hemosiderosis
Clinical Classifications group individual ICD-10-CM diagnosis codes into broader, clinically meaningful categories. These categories help simplify complex data by organizing related conditions under common clinical themes.
They are especially useful for data analysis, reporting, and clinical decision-making. Even when diagnosis codes differ, similar conditions can be grouped together based on their clinical relevance. Each category is assigned a unique CCSR code that represents a specific clinical concept, often tied to a body system or medical specialty.
CCSR Code: RSP016
Inpatient Default: X - Not applicable.
Outpatient Default: X - Not applicable.
Hemosiderosis
conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the mononuclear phagocyte system, without demonstrable tissue damage. the name refers to the presence of stainable iron in the tissue in the form of hemosiderin.
Hemosiderosis, Pulmonary
iron deposition within the lung. primary pulmonary hemosiderosis is characterized by hemoptysis; iron-deficiency anemia, and diffuse pulmonary hemorrhage as seen as transient pulmonary infiltrates on radiography. even though large amounts of iron are laid down in the lung, with normal or increased total body iron, anemia occurs because of inability of the erythron to use iron sequestered in pulmonary macrophages.
Mononuclear Phagocyte System
mononuclear cells with pronounced phagocytic ability that are distributed extensively in lymphoid and other organs. it includes macrophages and their precursors; phagocytes; kupffer cells; histiocytes; dendritic cells; langerhans cells; and microglia. the term mononuclear phagocyte system has replaced the former reticuloendothelial system, which also included less active phagocytic cells such as fibroblasts and endothelial cells. (from illustrated dictionary of immunology, 2d ed.)
The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.
Inclusion Terms
- Essential brown induration of lung
Code First
- underlying disease, such as:
- disorders of iron metabolism E83.1
Type 1 Excludes
- acute idiopathic pulmonary hemorrhage in infants AIPHI R04.81
References found for this diagnosis code in the External Cause of Injuries Index:
- Induration, indurated
- lung (black) (chronic) (fibroid)
- essential brown
- lung (black) (chronic) (fibroid)
The Medicare Code Editor (MCE) detects errors and inconsistencies in ICD-10-CM diagnosis coding that can affect Medicare claim validity. These Medicare code edits help medical coders and billing professionals determine when a diagnosis code is not appropriate as a principal diagnosis, does not meet coverage criteria. Use this list to verify whether a code is valid for Medicare billing and to avoid claim rejections or denials due to diagnosis coding issues.
Manifestation codes describe the manifestation of an underlying disease, not the disease itself, and therefore should not be used as a principal diagnosis.
Below are the ICD-9 codes that most closely match this ICD-10 code, based on the General Equivalence Mappings (GEMs). This ICD-10 to ICD-9 crosswalk tool is helpful for coders who need to reference legacy diagnosis codes for audits, historical claims, or approximate code comparisons.
ICD-9-CM: 516.1
This is a direct match with no additional mapping qualifiers. The absence of a flag generally means the mapping is considered exact or precise. In other words, the ICD-10 code maps cleanly to the ICD-9 code without qualification, approximation, or needing multiple codes.
Interstitial Lung Diseases
Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. The inflammation and scarring make it hard to get enough oxygen. The scarring is called pulmonary fibrosis.
Breathing in dust or other particles in the air is responsible for some types of interstitial lung diseases. Specific types include:
- Black lung disease among coal miners, from inhaling coal dust
- Farmer's lung, from inhaling farm dust
- Asbestosis, from inhaling asbestos fibers
- Siderosis, from inhaling iron from mines or welding fumes
- Silicosis, from inhaling silica dust
Other causes include autoimmune diseases or occupational exposures to molds, gases, or fumes. Some types of interstitial lung disease have no known cause.
Treatment depends on the type of exposure and the stage of the disease. It may involve medicines, oxygen therapy, or a lung transplant in severe cases.
FY 2026 - No Change, effective from 10/1/2025 through 9/30/2026
FY 2025 - No Change, effective from 10/1/2024 through 9/30/2025
FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
